ProteomeLM contextual target evidence

HANSEN: Target Prioritization ?

Ranked Mycobacterium leprae target candidates for structure-guided drug discovery, integrating calibrated ProteomeLM-L-leprae essentiality, predicted pockets, AF2Bind, Boltz2 model confidence, functional annotation, pathway annotation and tractability.

Interpretation
This page ranks Mycobacterium leprae proteins as candidate targets for structure-guided drug discovery. The Target Priority Score is a weighted combination of five components: Score = 100 × [0.35 × essentiality + 0.25 × binding site + 0.20 × annotation + 0.10 × model quality + 0.10 × tractability]. The essentiality component is the Platt-calibrated ProteomeLM-L-leprae probability. Tiers are assigned from this score alone, with no other criterion: high-priority ≥67, strong candidate ≥61, moderate candidate ≥50, exploratory <50. The score is a computational shortlist for triage, not a validated measure of essentiality or druggability.
Ranked Targets

1603

High Priority

50

Strong

125

With Pockets

1603

With AF2Bind

1603

Ranked Target Candidates

Search, filter and prioritise candidates for downstream structure-guided drug discovery workflows.

Rank ? ML ID ? Gene ? Protein ? Priority ? Tier ? ProteomeLM ? Pockets/AF2Bind ? Model ? Annotation ? Rationale ?
Loading target-prioritization results…

How this ranking is generated

Target Priority Score integrates calibrated ProteomeLM-L-leprae essentiality, Boltz2 model confidence, pocket and AF2Bind binding predictions, functional annotation and tractability.

Read methods in Help